These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
77-0390628
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification Number)
|
|
|
308 Dorla Court, Suite 206
|
|
|
| Zephyr Cove, Nevada | 89448 | |
|
(Address of principal executive offices)
|
(Zip Code))
|
|
Large accelerated filer
o
|
Accelerated filer
x
|
Non-accelerated filer
o
|
Smaller reporting company
o
|
| (Do not check if a smaller reporting company) |
|
|
·
|
THE DESCIPTION OF OUR BUSINESS INCLUDES A STATEMENT THAT WE INTEND TO MARKET OUR GABRIEL CONNECTION TECHNOLOGY™. AN IMPLICATION OF THIS STATEMENT MAY BE THAT WE WILL BE ABLE TO SUCCESSFULLY MARKET THIS TECHNOLOGY AND THAT IT WILL GENERATE REVENUE IN THE FUTURE. IN FACT, THERE ARE MANY FACTORS WHICH WILL IMPACT THE SUCCESS OF THIS TECHNOLOGY FOR US, INCLUDING SEVERAL FACTORS WHICH ARE BEYOND OUR CONTROL, SUCH AS THE DEMAND FOR THIS TECHNOLOGY BY POTENTIAL CUSTOMERS AND THE LEVEL OF COMPETITION IN OUR BUSINESS.
|
|
|
·
|
THE DESCRIPTION OF OUR BUSINESS INCLUDES STATEMENTS RELATING TO OUR INTENT TO ESTABLISH A SECURE DOMAIN NAME REGISTRY IN THE U.S. AND OTHER PARTS OF THE WORLD, THAT WE ARE CONSIDERING MAKING APPLICATIONS TO BECOME ACCREDITED TO DO SO UNDER AUTHORITY OF THE U.S. GOVERNMENT. THE IMPLICATION OF THOSE STATEMENTS IS THAT WE WILL BE ABLE TO ESTABLISH A REGISTRY THAT WILL HAVE MARKET ACCEPTANCE AND THAT IT WILL GENERATE REVENUE FOR US IN THE FUTURE. THERE ARE MANY FACTORS WHICH WILL IMPACT OUR ABILITY TO SUCCESSFULLY ESTABLISH A DOMAIN NAME REGISTRY, INCLUDING SEVERAL FACTORS WHICH ARE BEYOND OUR CONTROL, SUCH AS THE ACCREDITATION APPLICATION PROCESS OR THE ACCEPTANCE OF OUR REGISTRY OVER OTHERS IN THE MARKET, PARTICULARLY IF WE DETERMINE TO ESTABLISH A REGISTRY WITHOUT ACCREDITATION.
|
|
|
·
|
THE STATEMENTS THAT WE HAVE SUBMITTED A LICENSING DECLARATION TO THE 3
RD
GENERATION PARTNERSHIP, OR 3GPP, UPDATED SUCH DECLARATIONS AT THE REQUEST OF THE EUROPEAN TELECOMMUNICATIONS STANDARDS INSTITUTE, OR ETSI, AND THE
ALLIANCE FOR TELECOMMUNICATIONS INDUSTRY SOLUTIONS, OR ATIS
, AND THAT WE BELIEVE WE ARE POSITIONED TO LICENSE OUR PATENTS TO 3GPP MEMBERS, DESIRING TO IMPLEMENT THE TECHNICAL SPECIFICATIONS IDENTIFIED BY US, MAY IMPLY THAT THE PATENTS WE HAVE IDENTIFIED TO 3GPP WILL GENERATE LICENSING REVENUE FOR US IN THE FUTURE. WE CANNOT ASSURE YOU THAT WE WILL BE SUCCESSFUL IN LICENSING OUR PATENTS OR THAT THIRD PARTIES WILL BE WILLING TO ENTER INTO LICENSES WITH US ON REASONABLE TERMS OR AT ALL.
|
|
|
·
|
OUR STATEMENT THAT WE BELIEVE WE HAVE THE FINANCIAL AND OTHER RESOURCES TO COMPLETE OUR BUSINESS PLAN MAY IMPLY THAT OUR RESOURCES WILL BE SUFFICIENT TO COMPLETE THAT PLAN SUCCESSFULLY. HOWEVER, WE MAY NOT BE ABLE TO SUCCESSFULLY IMPLEMENT OUR BUSINESS PLAN FOR MANY REASONS, INCLUDING MANY REASONS THAT ARE BEYOND OUR CONTROL, SUCH AS THE POSSIBILITY THAT OUR FINANCIAL RESOURCES BECOME EXHAUSTED DUE TO INCREASED COSTS ASSOCIATED WITH OUR ATTEMPTS TO COMPETE WITH OTHERS WHO MAY HAVE GREATER RESOURCES, OR DUE TO OUR OTHER ACTIVITIES, INCLUDING OUR LITIGATION ACTIVITIES.
|
|
|
·
|
WE CANNOT ASSURE YOU WE WILL PREVAIL IN OUR PENDING LITIGATION MATTERS AND ANY ADVERSE RULING MAY HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS. ALSO, THE LEGAL AND OTHER COSTS WE MAY INCUR IN CONNECTION WITH LITIGATION MATTERS WILL DEPEND, IN PART, UPON ACTIONS TAKEN BY OTHER PARTIES, WHICH ACTIONS ARE NOT WITHIN OUR CONTROL AND THESE COSTS MAY HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS.
|
|
|
·
|
OUR REFERENCES TO THE FACT THAT OUR CORE DEVELOPMENT TEAM HAS SPENT OVER 10 YEARS WORKING TOGETHER, THEIR PRIOR SUCCESSES AT SAIC AND SAIC ITSELF MAY IMPLY THAT OUR TEAM WILL BE SUCCESSFUL IN THE FUTURE. HOWEVER, THIS TEAM MAY NOT BE SUCCESSFUL FOR MANY REASONS, INCLUDING MANY REASONS THAT ARE BEYOND OUR CONTROL, SUCH AS THE POSSIBILITY THAT ONE OR MORE KEY MEMBERS OF THE TEAM BECOMES INCAPACITATED, OR THAT COMPETITORS ARE SUCCESSFUL IN DEVELOPING SUPERIOR PRODUCTS.
|
|
|
·
|
THE IMPACT OF CHANGES IN THE US AND GLOBAL ECONOMIES IN GENERAL AND THE CAPITAL MARKETS ON US AND OUR INTENDED CUSTOMERS;
|
|
|
·
|
COMPLIANCE WITH, AND CHANGES TO, U.S. FEDERAL, STATE AND LOCAL LAWS AND REGULATIONS, FOREIGN LAWS AND REGULATIONS, ACCOUNTING RULES, TAX RATES AND SIMILAR MATTERS;
|
|
|
·
|
COMPETITION WITHIN OUR INDUSTRY; AND
|
|
|
·
|
IF THE RECENT DIFFICULT U.S. AND GLOBAL ECONOMIC CONDITIONS CONTINUE, WORSEN OR LAST FOR AN EXTENDED PERIOD, WE MAY FIND IT DIFFICULT OR IMPOSSIBLE TO MARKET OUR PRODUCTS AND WE MAY SUFFER CONTINUING LOSSES OR FAIL.
|
| Page | ||
| PART I — FINANCIAL INFORMATION | 1 | |
| Item 1 — Financial Statements. | 1 | |
| Condensed Consolidated Balance Sheets at September 30, 2011 and December 31, 2010 | 1 | |
| Condensed Consolidated Statements Of Operations for the three and nine months ended September 30, 2011 and 2010 | 2 | |
| Condensed Consolidated Statements Of Cash Flows for the nine months ended September 30, 2011 and 2010 | 3 | |
| Notes to Condensed Consolidated Financial Statements | 4 | |
| Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations | 11 | |
| Item 3 — Quantitative and Qualitative Disclosures About Market Risk | 16 | |
| Item 4 — Controls and Procedures | 16 | |
| PART II — OTHER INFORMATION | 18 | |
| Item 1 — Legal Proceedings | 18 | |
| Item 1A — Risk Factors | 18 | |
| Item 6 — Exhibits | 30 | |
| SIGNATURES | 31 | |
| EXHIBIT INDEX | 32 | |
|
September 30,
2011
|
December 31,
2010
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 50,620 | $ | 34,635 | ||||
|
Investments
|
14,611 | 43,457 | ||||||
|
Accounts receivable, net
|
— | 3 | ||||||
|
Prepaid taxes
|
10,023 | — | ||||||
|
Current deferred tax benefit
|
2 | 1,735 | ||||||
|
Prepaid expense and other current assets
|
391 | 87 | ||||||
|
Total current assets
|
75,647 | 79,916 | ||||||
|
Property and equipment, net
|
28 | 25 | ||||||
|
Intangible and other assets
|
72 | 108 | ||||||
|
Long-term deferred tax benefit, net
|
29 | 1,645 | ||||||
|
Total assets
|
$ | 75,776 | $ | 81,694 | ||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued liabilities
|
$ | 1,012 | $ | 519 | ||||
|
Income tax liability
|
— | 7,358 | ||||||
|
Derivative liability
|
2,739 | 14,364 | ||||||
|
Total current liabilities
|
3,751 | 22,241 | ||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock, par value $0.0001 per share
|
||||||||
|
Authorized: 10,000,000 shares, issued and outstanding: 0 shares at September 30, 2011, and December 31, 2010, respectively
|
— | — | ||||||
|
Common stock, par value $0.0001 per share
|
||||||||
|
Authorized: 100,000,000 shares, issued and outstanding: 50,481,636 shares at September 30, 2011, and 49,341,028 at December 31, 2010
|
5 | 5 | ||||||
|
Additional paid in capital
|
101,809 | 78,187 | ||||||
|
Accumulated deficit
|
(29,758 | ) | (17,755 | ) | ||||
|
Accumulated other comprehensive loss
|
(31 | ) | (984 | ) | ||||
|
Total stockholders’ equity
|
72,025 | 59,453 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 75,776 | $ | 81,694 | ||||
|
Three Months
Ended
September 30,
2
011
|
Three Months
Ended
September 30,
2010
|
|||||||
|
Revenue — royalties
|
$ | 3 | $ | 15 | ||||
|
Operating expense:
|
||||||||
|
Research and development
|
273 | 193 | ||||||
|
General, selling and administrative
|
3,910 | 2,256 | ||||||
|
Total operating expense
|
4,183 | 2,449 | ||||||
|
Loss from operations
|
(4,180 | ) | (2,434 | ) | ||||
|
Gain (loss) on change in value of embedded derivative and warrants
|
8,555 | (23,266 | ) | |||||
|
Interest and other income, net
|
44 | 80 | ||||||
|
Income (loss) before taxes
|
4,419 | (25,620 | ) | |||||
|
Income tax benefit
|
1,460 | (200 | ) | |||||
|
Net Income (loss)
|
$ | 5,879 | $ | (25,420 | ) | |||
|
Basic earnings (loss) per share:
|
$ | 0.12 | $ | (0.54 | ) | |||
|
Diluted earnings (loss) per share:
|
$ | 0.11 | $ | (0.54 | ) | |||
|
Weighted average shares outstanding basic
|
50,342 | 47,427 | ||||||
|
Weighted average shares outstanding diluted
|
54,543 | 47,427 | ||||||
|
Nine months
Ended
September 30,
2011
|
Nine months
Ended
September 30,
2010
|
|||||||
|
Revenue — royalties
|
$ | 20 | $ | 60 | ||||
|
Operating expense:
|
||||||||
|
Royalty expense
|
— | 59,239 | ||||||
|
Research and development
|
705 | 1,943 | ||||||
|
General, selling and administrative
|
10,003 | 30,667 | ||||||
|
Gain on settlement
|
— | (200,000 | ) | |||||
|
Total operating (expense) income
|
(10,708 | ) | 108,151 | |||||
|
Income (loss) from operations
|
(10,688 | ) | 108,211 | |||||
|
Loss on change in value of embedded derivative and warrants
|
(3,634 | ) | (30,248 | ) | ||||
|
Interest and other income, net
|
173 | 93 | ||||||
|
Income (loss) before taxes
|
(14,149 | ) | 78,056 | |||||
|
Income tax expense (benefit)
|
(3,100 | ) | 33,800 | |||||
|
Net Income (loss)
|
$ | (11,049 | ) | $ | 44,256 | |||
|
Basic earnings (loss) per share:
|
$ | (0.22 | ) | $ | 1.00 | |||
|
Diluted earnings (loss) per share:
|
$ | (0.22 | ) | $ | 0.93 | |||
|
Weighted average shares outstanding basic
|
49,854 | 44,306 | ||||||
|
Weighted average shares outstanding diluted
|
49,854 | 47,669 | ||||||
|
Nine months
Ended
September 30,
2011
|
Nine months
Ended
September 30,
2010
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income (loss)
|
$ | (11,049 | ) | $ | 44,256 | |||
|
Adjustments to reconcile net income (loss) to net cash used in operating activities:
|
||||||||
| Depreciation and amortization | 45 | 44 | ||||||
|
Stock-based compensation
|
3,104 | 2,473 | ||||||
|
Excess tax benefits from stock-based award activities
|
1,348 | — | ||||||
|
Net change in deferred taxes
|
3,349 | (2,600 | ) | |||||
|
Change in value of derivative liability
|
3,634 | 30,248 | ||||||
|
Changes in assets and liabilities:
|
||||||||
|
Receivables and other current assets
|
(301 | ) | (79 | ) | ||||
|
Pre paid taxes
|
(10,023 | ) | — | |||||
|
Accounts payable and accrued liabilities
|
493 | 3,126 | ||||||
|
Income tax liability
|
(7,358 | ) | — | |||||
|
Net cash provided by (used in) operating activities
|
(16,758 | ) | 77,468 | |||||
|
Cash flows from investing activities:
|
||||||||
|
Purchase of property and equipment
|
(12 | ) | (6 | ) | ||||
|
Proceeds from sale of investments, net
|
28,846 | — | ||||||
|
Net cash provided by (used in) investing activities
|
28,834 | (6 | ) | |||||
|
Cash flows from financing activities:
|
||||||||
|
Payment of royalty obligation less imputed interest
|
— | (160 | ) | |||||
|
Payment of dividend
|
— | (23,599 | ) | |||||
|
Proceeds from exercise of options
|
845 | 283 | ||||||
|
Proceeds from exercise of warrants
|
3,064 | 18,552 | ||||||
|
Net cash provided by (used in) financing activities
|
3,909 | (4,924 | ) | |||||
|
Net increase in cash and cash equivalents
|
15,985 | 72,538 | ||||||
|
Cash and cash equivalents, beginning of period
|
34,635 | 2,011 | ||||||
|
Cash and cash equivalents, end of period
|
$ | 50,620 | $ | 74,549 | ||||
|
Supplemental disclosure of cash flow information:
|
||||||||
|
Cash paid during the period for taxes
|
$ | 9,600 | $ | 29,200 | ||||
|
Cash paid during the period for interest
|
$ | — | $ | 10 | ||||
|
Supplemental disclosure of noncash investing and financing activities:
|
||||||||
|
In April 2011 a cashless exercise of 30,000 underwriter warrants at $4.80 resulted in the issuance of 24,178 common shares.
|
||||||||
|
|
·
|
persuasive evidence of sales arrangements;
|
|
|
·
|
delivery has occurred or services have been rendered;
|
|
|
·
|
the buyer’s price is fixed or determinable; and
|
|
|
·
|
collection is reasonably assured.
|
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
||||
|
Certificates of deposit
|
|
$
|
3,083,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
3,083,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Bonds:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AA
|
|
|
2,229,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,229,000
|
|
| A |
|
|
9,299,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
9,299,000
|
|
|
Total Corporate Bonds
|
|
|
11,528,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
11,528,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments at Fair Value
|
|
$
|
14,611,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
14,611,000
|
|
|
|
Quoted
Prices in
Active
Markets for
Identical
Assets
|
Significant
Other
Observable
Inputs
|
Significant
Unobservable
Inputs
|
|||||||||||||
|
|
(Level 1) | (Level 2) |
(Level 3)
|
Total
|
||||||||||||
|
Series l Warrants
|
$ | — | $ | — | $ | 2,739,000 | $ | 2,739,000 | ||||||||
|
Total
|
$ | — | $ | — | $ | 2,739,000 | $ | 2,739,000 | ||||||||
|
|
|
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level
3)
|
|
|
|
Balance December 31, 2010
|
|
$
|
14,364,000
|
|
|
Net loss included in earnings
|
|
|
3,634,000
|
|
|
Settlements
|
|
|
(15,259,000
|
)
|
|
Balance September 30, 2011
|
|
$
|
2,739,000
|
|
|
September 30,
2011
|
September 30,
2010
|
|||||||
|
Current
|
$ | (6,400,000 | ) | $ | 36,400,000 | |||
|
Deferred
|
3,300,000 | (2,600,000 | ) | |||||
|
Total
|
$ | (3,100,000 | ) | $ | 33,800,000 | |||
|
September 30,
2011
|
September 30,
2010
|
|||||||
|
Tax (benefit) expense at the federal statutory rate
|
$ | (4,900,000 | ) | $ | 26,700,000 | |||
|
State taxes, net of federal benefit
|
(500,000 | ) | 5,000,000 | |||||
|
Prior year true-up
|
(100,000 | ) | — | |||||
|
Non-deductible change in derivative liability
|
1,300,000 | 11,200,000 | ||||||
|
Change in deferred tax allowance
|
800,000 | (9,500,000 | ) | |||||
|
Stock option expense
|
300,000 | — | ||||||
|
Other
|
— | 400,000 | ||||||
|
Total
|
$ | (3,100,000 | ) | $ | 33,800,000 | |||
|
September 30,
2011
|
September 30,
2010
|
|||||||
|
Deferred tax benefit of net operating loss carryforwards
|
$ | 2,300,000 | $ | 1,500,000 | ||||
|
California franchise tax deduction
|
(3,300,000 | ) | 2,700,000 | |||||
|
Other
|
(500,000 | ) | 3,800,000 | |||||
|
Subtotal
|
(1,500,000 | ) | 8,000,000 | |||||
|
Less utilization allowance
|
(1,800,000 | ) | (5,400,000 | ) | ||||
|
Total
|
$ | (3,300,000 | ) | $ | 2,600,000 | |||
|
Original
Number of
Warrants
Issued
|
Exercise
Price per
Common
Share
|
Exercisable
at December
31, 2010
|
Became
Exercisable
|
Exercised
|
Terminated /
Cancelled /
Expired
|
Exercisable
at
September
30, 2011
|
Expiration Date
|
||||||||||||||||||||
|
300,000
|
$ | 4.80 | 30,000 | — | (30,000 | ) | — | — |
December 2012
|
||||||||||||||||||
|
2,619,036 (1)
|
$ | 3.59 | 1,060,444 | — | (855,536 | ) | — | 204,908 |
March 2015
|
||||||||||||||||||
|
Total
|
1,090,444 | (885,536 | ) | — | 204,908 | ||||||||||||||||||||||
|
|
(1)
|
Referred to as our Series I Warrants.
|
|
|
·
|
Although we entered into a Settlement and License Agreement with Microsoft Corporation, we may not be successful in entering into further licensing relationships;
|
|
|
·
|
Third parties may challenge the validity of certain of our patents;
|
|
|
·
|
We expect that the market opportunities we have identified will attract intense competition new and established competitors who may have superior products and services or better marketing, financial or other capacities than we do; and
|
|
|
·
|
It is possible that one or more of our potential customers or licensees develops or otherwise sources products or technologies similar to, competitive with or superior to ours.
|
|
|
·
|
New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue.
|
|
|
·
|
More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO.
|
|
|
·
|
Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer.
|
|
|
·
|
As patent enforcement becomes more prevalent, it may become more difficult for us to voluntarily license our patents.
|
|
|
·
|
The need to educate potential customers about our patent rights and our product and service capabilities;
|
|
|
·
|
Customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products;
|
|
|
·
|
Customers’ budgetary constraints;
|
|
|
·
|
The timing of customers’ budget cycles; and
|
|
|
·
|
Delays caused by customers’ internal review processes.
|
|
|
·
|
Long sales cycles may increase the risk that our financial resources are exhausted before we are able to generate significant revenue.
|
|
|
·
|
power loss, transmission cable cuts and other telecommunications failures;
|
|
|
·
|
damage or interruption caused by fire, earthquake, and other natural disasters;
|
|
|
·
|
computer viruses or software defects; and
|
|
|
·
|
physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control.
|
|
|
·
|
developments in any then-outstanding litigation;
|
|
|
·
|
quarterly variations in our operating results;
|
|
|
·
|
large purchases or sales of common stock;
|
|
|
·
|
actual or anticipated announcements of new products or services by us or competitors;
|
|
|
·
|
general conditions in the markets in which we compete; and
|
|
|
·
|
economic and financial conditions.
|
|
|
·
|
the outcome of enforcement actions currently in progress or that we may undertake in the future, and the timing thereof;
|
|
|
·
|
the amount and timing of receipt of license fees from potential infringers, licensees or customers;
|
|
|
·
|
the outcome of actions we have taken and may take in the future to enforce our intellectual property rights;
|
|
|
·
|
the rate of adoption of our patented technologies;
|
|
|
·
|
the number of new license arrangements we may execute, or that may expire, within a particular period and the scope of those licenses, including the number of our patents which are licensed, the extent of prior infringement of our patent rights, royalty rates, timing of payment obligations, expiration date etc;
|
|
|
·
|
the success of a licensee in selling products that use our patented technologies; and
|
|
|
·
|
the amount and timing of expenses related to our patent filings and enforcement proceedings, including litigation, related to our intellectual property rights.
|
|
|
·
|
A staggered Board of Directors
: This means that only one or two directors (since we have a five-person Board of Directors) will be up for election at any given annual meeting. This has the effect of delaying the ability of stockholders to effect a change in control of us because it would take two annual meetings to effectively replace a majority of the Board of Directors.
|
|
|
·
|
Blank check preferred stock
: Our Board of Directors has the authority to establish the rights, preferences and privileges of our 10,000,000 authorized, but unissued, shares of preferred stock. Therefore, this stock may be issued at the discretion of our Board of Directors with preferences over your shares of our common stock in a manner that is materially dilutive to you. In addition, blank check preferred stock can be used to create a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of Directors. We have not adopted such a “poison pill;” but our Board of Directors has the ability to do so in the future, very rapidly and without stockholder approval.
|
|
|
·
|
Advance notice requirements for director nominations and for new business to be brought up at stockholder meetings
: Stockholders wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows and in very specific form in order to have the matter voted on at a stockholder meeting. This has the effect of giving our Board of Directors and management more time to react to stockholder proposals generally and could also have the effect of disregarding a stockholder proposal or deferring it to a subsequent meeting to the extent such proposal is not raised properly.
|
|
|
·
|
No stockholder actions by written consent
: No stockholder or group of stockholders may take actions rapidly and without prior notice to our Board of Directors and management or to the minority stockholders. Along with the advance notice requirements described above, this provision also gives our Board of Directors and management more time to react to proposed stockholder actions.
|
|
|
·
|
Super majority requirement for stockholder amendments to the By-laws
: Stockholder proposals to alter or amend our By-laws or to adopt new By-laws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares of our common stock.
|
|
|
·
|
No ability of stockholders to call a special meeting of the stockholders
: Only the Board of Directors or management can call special meetings of the stockholders. This could mean that stockholders, even those who represent a significant percentage of our shares of common stock, may need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders.
|
|
Exhibit
Number
|
Description
|
|
|
31.1
|
Certification of the President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.1*
|
Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2*
|
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101**
|
Interactive Data Files
|
|
*
|
This exhibit is furnished herewith, but not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section. Such certifications will not be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, except to the extent that we explicitly incorporate them by reference.
|
|
VIRNETX HOLDING CORPORATION
|
|||
|
|
By:
|
/s/ Kendall Larsen | |
| Name |
Kendall Larsen
|
||
|
Chief Executive Officer (Principal Executive Officer)
|
|||
| By: | /s/ William E. Sliney | ||
| Name | William E. Sliney | ||
| Title | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | ||
| Date: November 09, 2011 | |||
|
Exhibit
Number
|
Description
|
|
|
Certification of the President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
|
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
|
101**
|
Interactive Data Files
|
|
*
|
This exhibit is furnished herewith, but not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section. Such certifications will not be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, except to the extent that we explicitly incorporate them by reference.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|